Biomarkers in Medicine : responding to the needs of an emerging community
Targeted diagnostics and therapeutics for individualized patient management
New biomarkers in breast cancer: microRNAs and leptins – where are we now?
Damaged-DNA technology reveals cancer early
First test to potentially identify patients who will react badly to radiotherapy
Method to identify molecular predictors of drug response
Telomere length could predict coronary heart disease
Genetic risk factors for prostate cancer identified
Analyzing the methylation state of DNA recovered from exhaled breath to detect lung cancer
On target? The challenge of integrating biomarker research in drug development
Imaging and molecular biomarkers of vulnerable atheromatous plaques
Emerging role of the apelin system in cardiovascular homeostasis
Early detection of acute coronary syndromes and risk stratification by multimarker analysis
Aspects of β-amyloid as a biomarker for Alzheimer's disease
Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease
Symptomatic treatment of Alzheimer's disease: identification of biomarkers to aid translation from bench to bedside
Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity
Low high-density lipoprotein cholesterol may signal breast cancer risk: recent findings and new hypotheses
Biomarkers in neonatal infection
Homocysteine: biomarker or cause of adverse pregnancy outcome?
Future of liquid chromatography–mass spectrometry in metabolic profiling and metabolomic studies for biomarker discovery
Mucosally restricted antigens as novel immunological targets for antitumor therapy
Assessing the roles of EGFR gene copy number, protein expression and mutation in predicting outcomes in non-small-cell lung cancer after treatment with EGFR inhibitors
Early advances of α1-antitrypsin precursor using the proteomic approach in gastric juice